Dr Conor Kearney
Honorary Fellow
The Sir Peter MacCallum Department of Oncology
52 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Abstract B021: Genome-wide CRISPR Screen Identifies Menin as a Mediator of Encorafenib Plus Cetuximab Resistance in BRAF V600E-mutant Colorectal Cancer
DOI: 10.1158/1538-7445.rasoncother26-b0212026
Journal article
CRISPR screens define unified hallmarks of cancer cell-autonomous immune evasion
DOI: 10.1016/j.celrep.2025.1167382026
Journal article
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity
DOI: 10.1016/j.celrep.2025.1166652025
Journal article
Abstract A007: Calcitonin gene-related peptide (CGRP) and receptor activity-modifying protein 1 (RAMP1) drive tumor cell growth in early-onset human gastric cancer
DOI: 10.1158/1557-3265.earlyonsetca25-a0072025
Conference Proceedings
360 Understanding the mechanisms of tumor immune evasion from Vδ1 γδ T cell-mediated killing using genome-wide CRISPR-Cas9 loss-of-function screens
DOI: 10.1136/jitc-2025-sitc2025.03602019
Research grants (other domestic)
Enhancing Immune Cell Trafficking to Tumours to Improve the Therapy of Breast Cancer
2018
Research Grant
Novel Therapies to Enhance Anti-Tumour Immunity
RECENT SCHOLARLY WORKS
2025
Journal article
Abstract A074: DUSP4 loss: A novel driver of colorectal cancer
DOI: 10.1158/1535-7163.targ-25-a0742025
Journal article
Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancers
DOI: 10.1136/bmjonc-2025-0008422024
Journal article
Intracellular zinc protects tumours from T cell-mediated cytotoxicity
DOI: 10.1038/s41418-024-01369-42024
Journal article
Tumor immune evasion: insights from CRISPR screens and future directions
DOI: 10.1111/febs.170032024
Journal article
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity
DOI: 10.1016/j.celrep.2024.113831